ISGD Welcomes CMSO Barbara S. Gillespie
The International Society of Glomerular Disease is pleased to welcome Barbara Gillespie, MD, MMS, FASN, into the advisory role of Chief Medical and Strategy Officer. In this capacity she will strengthen collaboration across the glomerular disease ecosystem to advance scientific and clinical development, novel therapies, and key ISGD initiatives, including Centers of Excellence, endpoint initiative
January 1, 2026